Tasleem Arif

Years Active: 2018-2021
Publications (10 Years): 5

Icahn School of Medicine at Mount Sinai

Ben-Gurion University of the Negev (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Icahn School of Medicine at Mount Sinai Jul 10 2017

United States

Post Doctoral Fellow :: Cell Developmental and Reg Biology

Ben-Gurion University of the Negev Nov 06 2016 - Mar 28 2017

Israel

Post Docotrol :: Life Sciences

Education History

Ben-Gurion University of the Negev Aug 01 2012 - Feb 18 2017

Israel

PHD :: Life Science

Publications

Raymond Liang, Vijay Menon, Jiajing Qiu, Tasleem Arif, Santosh Renuse, Miao Lin, Roberta Nowak, Boris M Hartmann, Nikolaos Tzavaras, Deanna L Benson, Jerry Edward Chipuk, Miguel Fribourg, Akhilesh Pandey, Velia M Fowler, Saghi Ghaffari
Mitochondrial localization and moderated activity are key to murine erythroid enucleation. Blood advances 5 (10) (2021)
Erez Zerbib, Tasleem Arif, Anna Shteinfer-Kuzmine, Vered Chalifa-Caspi, Varda Shoshan-Barmaz
VDAC1 Silencing in Cancer Cells Leads to Metabolic Reprogramming That Modulates Tumor Microenvironment. Cancers 13 (11) (2021)
Zohar Amsalem, Tasleem Arif, Anna Shteinfer-Kuzmine, Vered Chalifa-Caspi, Varda Shoshan-Barmaz
The Mitochondrial Protein VDAC1 at the Crossroads of Cancer Cell Metabolism: The Epigenetic Link. Cancers 12 (4) (2020)
Anna Shteinfer-Kuzmine, Zohar Amsalem, Tasleem Arif, Alexandra Zooravlov, Varda Shoshan-Barmaz
Selective induction of cancer cell death by VDAC1-based peptides and their potential use in cancer therapy. Molecular oncology 12 (7) (2018)
Tasleem Arif, Avijit Paul, Yakov Krelin, Anna Shteinfer-Kuzmine, Varda Shoshan-Barmaz
Mitochondrial VDAC1 Silencing Leads to Metabolic Rewiring and the Reprogramming of Tumour Cells into Advanced Differentiated States. Cancers 10 (12) (2018)

Tasleem Arif.css-eqlu8i{font-size:small;padding-left:4px;}